TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer.
Troponin T1 (TNNT1) is a subunit of troponin that has been linked to neuromuscular disorder. Recently, it is reported that TNNT1 facilitates proliferation of breast cancer cells. Interestingly, The Cancer Genome Atlas (TCGA) data indicates that its overexpression is associated with unfavorable prognosis of colorectal cancer (CRC) patients. This study aims to explore the expression, function and mechanism of dysregulation of TNNT1 in CRC. Immunohistochemical staining and real-time PCR were used to compare the expression level of TNNT1 in CRC tissues and adjacent tissues. Western blot was used to detect the expression of TNNT1 in cell lines. Kaplan-meier analysis and chi-square test were applied to evaluate the potential of TNNT1 to function as a cancer biomarker. RNA interference was used to inhibit TNNT1 expression in CRC cells, followed by detecting cell proliferation, apoptosis, migration and invasion. Luciferase reporter gene assay was used to determine the regulatory relationship between miR-873 and TNNT1. In this study, we validated that TNNT1 was significantly up-regulated in CRC samples and cell lines. It was also demonstrated that the up-regulation of TNNT1 was associated with several clinicopathologic features, and its high expression was correlated with unfavorable prognosis of the patients. Knockdown of TNNT1 remarkably arrested the proliferation, migration and invasion, while promoted apoptosis. TNNT1 was identified as a target gene of miR-873, and they had negative correlation among CRC samples. In conclusion, we demonstrated that TNNT1, regulated by miR-873, was an oncogene of CRC associated with patients' prognosis.